MedPath

MEPRON

MEPRON

Approved
DIN Number

02217422

Drug Class

Human

Market Date

Sep 10, 1996

Company
HC

GlaxoSmithKline Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02217422
AIG Number0124073001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
P01AX06 ATOVAQUONE
Product Specifications
Dosage FormSuspension
Route of AdministrationOral
AHFS Classification08:30.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATOVAQUONEActive
Strength: 750 MG / 5 ML
Monograph: ATOVAQUONE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.